Stevanato Group (NYSE:STVN) Updates FY 2025 Earnings Guidance

Stevanato Group (NYSE:STVN) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.544-0.587 for the period, compared to the consensus earnings per share estimate of 0.570. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Wall Street Analyst Weigh In

STVN has been the topic of several analyst reports. Bank of America lifted their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Morgan Stanley restated an “equal weight” rating and set a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Finally, Wolfe Research began coverage on shares of Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of €28.60 ($30.75).

Stevanato Group Trading Down 2.5 %

Shares of NYSE:STVN opened at €18.84 ($20.26) on Thursday. The stock’s fifty day moving average price is €21.40 and its 200-day moving average price is €20.51. Stevanato Group has a 1 year low of €16.56 ($17.81) and a 1 year high of €33.49 ($36.01). The company has a market cap of $5.71 billion, a P/E ratio of 40.09, a PEG ratio of 7.18 and a beta of 0.56. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Sell-side analysts expect that Stevanato Group will post 0.5 earnings per share for the current year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.